HOMOLOGY MEDICINES INC (FIXX) Stock Analyst Ratings
NASDAQ:FIXX - Nasdaq - US4380831077 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 43% to FIXX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 1.53. This target is 63.69% above the current price.
FIXX was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about FIXX.
In the previous month the buy percentage consensus was at a similar level.
FIXX was analyzed by 6 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-07-28 | Baird | Downgrade | Outperform -> Neutral |
| 2023-05-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-12 | Chardan Capital | Maintains | Buy -> Buy |
| 2023-05-12 | Credit Suisse | Reiterate | Neutral -> Neutral |
| 2023-03-16 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-11-17 | Chardan Capital | Maintains | Buy |
| 2022-11-11 | RBC Capital | Maintains | Sector Perform |
| 2022-08-31 | Baird | Maintains | Outperform |
| 2022-08-16 | Chardan Capital | Maintains | Buy |
| 2022-08-16 | BTIG | Maintains | Buy |
| 2022-08-16 | Credit Suisse | Maintains | Neutral |
| 2022-05-17 | Credit Suisse | Maintains | Neutral |
| 2022-04-28 | Credit Suisse | Initiate | Neutral |
| 2022-02-28 | HC Wainwright & Co. | Maintains | Buy |
| 2022-02-22 | Chardan Capital | Maintains | Buy |
| 2022-02-22 | BTIG | Maintains | Buy |
| 2022-02-22 | Oppenheimer | Downgrade | Outperform -> Perform |
| 2022-02-22 | RBC Capital | Downgrade | Outperform -> Sector Perform |
| 2022-02-22 | B of A Securities | Maintains | Buy |
| 2021-11-16 | Chardan Capital | Maintains | Buy |
| 2021-03-02 | Stifel | Initiate | Hold |